Improving Access to Care for Veterans With Memory Loss
ConditionAlzheimer Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorVA Pittsburgh Healthcare System
About this trial
This study evaluates a care delivery protocol to improve access to care for Veterans with Alzheimer's Disease and Related Disorders (ADRD). A randomized controlled trial will enroll Veterans with mild cognitive impairment or early dementia at VA Pittsburgh. The ADRD care delivery protocol integrates telehealth, advanced diagnostics, and streamlined workflows to expedite screening for eligibility for amyloid targeting therapies.
Eligibility criteria
Qualifiers
Diagnosis of mild cognitive impairment or mild dementia due to suspected or confirmed AD with a 5 minute telephone MoCA score >7
Meets VA MUE inclusion/
Disqualifiers
Enrolled in VA care
Lives in a home setting (i.e., not in an institutional setting such as a nursing home, Community Living Center, or hospital)
Has a working telephone
18 years and older
Trial design
Treatments tested in this trial
- ADRD Care Delivery Protocol
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov